✦ LIBER ✦

CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia

✍ Scribed by Chim, C-S; Lau, J S; Wong, K-F; Kwong, Y-L

Book ID: 110056573
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 133 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preferential methylation of Wnt inhibito

Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor

✍ Chim, C-S; Chan, W W-L; Pang, A; Kwong, Y-L 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Is secondary leukemia an independent poo

Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?

✍ Richard A. Larson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Homozygous deletion of CDKN2A (p16, p14)

Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study

✍ Miyoung Kim; Seon-Hee Yim; Nam-Sun Cho; Seong-Ho Kang; Dae-Hyun Ko; Bora Oh; Tae 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Soluble vascular endothelial growth fact

Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes

✍ Qinglong Hu; Amanda L. Dey; Ying Yang; Yu Shen; Iman B. Jilani; Elihu H. Estey; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) are major regulators of angiogenesis, which plays a key role in the growth and dissemination of solid tumors and hematologic neoplasms. ## METHODS The authors measured the plasma concentrations of solu

Circulating angiopoietin-1 to angiopoiet

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple